Skip to main content
. 2018 Nov 14;4(2):e000757. doi: 10.1136/rmdopen-2018-000757

Figure 4.

Figure 4

ACR20/50/70 response rates at week 24 (TP1 per-protocol set). The per-protocol set consists of all patients completing the study until week 24 without major protocol deviations. Per-protocol set: GP2015 (n=168), ETN (n=155). ACR20/50/70, American College of Rheumatology 20%/50%/70% response criteria; ETN, reference etanercept; TP1, treatment period 1.